218 related articles for article (PubMed ID: 15049697)
1. Haptoglobin phenotypes differ in their ability to inhibit heme transfer from hemoglobin to LDL.
Bamm VV; Tsemakhovich VA; Shaklai M; Shaklai N
Biochemistry; 2004 Apr; 43(13):3899-906. PubMed ID: 15049697
[TBL] [Abstract][Full Text] [Related]
2. Ligand-dependent inequivalence of the α and β subunits of ferric human hemoglobin bound to haptoglobin.
Ascenzi P; De Simone G; Ciaccio C; Coletta M
J Inorg Biochem; 2020 Jan; 202():110814. PubMed ID: 31733428
[TBL] [Abstract][Full Text] [Related]
3. Reductive nitrosylation of ferric human hemoglobin bound to human haptoglobin 1-1 and 2-2.
Ascenzi P; De Simone G; Polticelli F; Gioia M; Coletta M
J Biol Inorg Chem; 2018 May; 23(3):437-445. PubMed ID: 29605886
[TBL] [Abstract][Full Text] [Related]
4. Haptoglobin: From hemoglobin scavenging to human health.
di Masi A; De Simone G; Ciaccio C; D'Orso S; Coletta M; Ascenzi P
Mol Aspects Med; 2020 Jun; 73():100851. PubMed ID: 32660714
[TBL] [Abstract][Full Text] [Related]
5. Human Hp1-1 and Hp2-2 phenotype-specific haptoglobin therapeutics are both effective in vitro and in guinea pigs to attenuate hemoglobin toxicity.
Lipiski M; Deuel JW; Baek JH; Engelsberger WR; Buehler PW; Schaer DJ
Antioxid Redox Signal; 2013 Nov; 19(14):1619-33. PubMed ID: 23418677
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of low-density lipoprotein oxidation by hemoglobin-derived iron.
Grinshtein N; Bamm VV; Tsemakhovich VA; Shaklai N
Biochemistry; 2003 Jun; 42(23):6977-85. PubMed ID: 12795592
[TBL] [Abstract][Full Text] [Related]
7. Oxidation of low-density lipoprotein by hemoglobin stems from a heme-initiated globin radical: antioxidant role of haptoglobin.
Miller YI; Altamentova SM; Shaklai N
Biochemistry; 1997 Oct; 36(40):12189-98. PubMed ID: 9315856
[TBL] [Abstract][Full Text] [Related]
8. Fluoride and azide binding to ferric human hemoglobin:haptoglobin complexes highlights the ligand-dependent inequivalence of the α and β hemoglobin chains.
Ascenzi P; di Masi A; De Simone G; Gioia M; Coletta M
J Biol Inorg Chem; 2019 Mar; 24(2):247-255. PubMed ID: 30706146
[TBL] [Abstract][Full Text] [Related]
9. In vivo and in vitro studies establishing haptoglobin as a major susceptibility gene for diabetic vascular disease.
Asleh R; Levy AP
Vasc Health Risk Manag; 2005; 1(1):19-28. PubMed ID: 17319095
[TBL] [Abstract][Full Text] [Related]
10. Role of hemopexin in protection of low-density lipoprotein against hemoglobin-induced oxidation.
Miller YI; Smith A; Morgan WT; Shaklai N
Biochemistry; 1996 Oct; 35(40):13112-7. PubMed ID: 8855948
[TBL] [Abstract][Full Text] [Related]
11. Complexity of a complex trait locus: HP, HPR, haemoglobin and cholesterol.
Guthrie PA; Rodriguez S; Gaunt TR; Lawlor DA; Smith GD; Day IN
Gene; 2012 May; 499(1):8-13. PubMed ID: 22433445
[TBL] [Abstract][Full Text] [Related]
12. Kinetics of cyanide and carbon monoxide dissociation from ferrous human haptoglobin:hemoglobin(II) complexes.
Ascenzi P; De Simone G; Tundo GR; Coletta M
J Biol Inorg Chem; 2020 May; 25(3):351-360. PubMed ID: 32146510
[TBL] [Abstract][Full Text] [Related]
13. The human protein haptoglobin inhibits IsdH-mediated heme-sequestering by
Mikkelsen JH; Runager K; Andersen CBF
J Biol Chem; 2020 Feb; 295(7):1781-1791. PubMed ID: 31819010
[TBL] [Abstract][Full Text] [Related]
14. Red cells, hemoglobin, heme, iron, and atherogenesis.
Nagy E; Eaton JW; Jeney V; Soares MP; Varga Z; Galajda Z; Szentmiklósi J; Méhes G; Csonka T; Smith A; Vercellotti GM; Balla G; Balla J
Arterioscler Thromb Vasc Biol; 2010 Jul; 30(7):1347-53. PubMed ID: 20378845
[TBL] [Abstract][Full Text] [Related]
15. Structure-function analysis of the antioxidant properties of haptoglobin.
Melamed-Frank M; Lache O; Enav BI; Szafranek T; Levy NS; Ricklis RM; Levy AP
Blood; 2001 Dec; 98(13):3693-8. PubMed ID: 11739174
[TBL] [Abstract][Full Text] [Related]
16. Depletion of haptoglobin and hemopexin promote hemoglobin-mediated lipoprotein oxidation in sickle cell disease.
Yalamanoglu A; Deuel JW; Hunt RC; Baek JH; Hassell K; Redinius K; Irwin DC; Schaer DJ; Buehler PW
Am J Physiol Lung Cell Mol Physiol; 2018 Nov; 315(5):L765-L774. PubMed ID: 30047285
[TBL] [Abstract][Full Text] [Related]
17. Quantitative mass spectrometry defines an oxidative hotspot in hemoglobin that is specifically protected by haptoglobin.
Pimenova T; Pereira CP; Gehrig P; Buehler PW; Schaer DJ; Zenobi R
J Proteome Res; 2010 Aug; 9(8):4061-70. PubMed ID: 20568812
[TBL] [Abstract][Full Text] [Related]
18. Engineering tyrosine residues into hemoglobin enhances heme reduction, decreases oxidative stress and increases vascular retention of a hemoglobin based blood substitute.
Cooper CE; Silkstone GGA; Simons M; Rajagopal B; Syrett N; Shaik T; Gretton S; Welbourn E; Bülow L; Eriksson NL; Ronda L; Mozzarelli A; Eke A; Mathe D; Reeder BJ
Free Radic Biol Med; 2019 Apr; 134():106-118. PubMed ID: 30594736
[TBL] [Abstract][Full Text] [Related]
19. Haptoglobin genotype and its role in determining heme-iron mediated vascular disease.
Goldenstein H; Levy NS; Levy AP
Pharmacol Res; 2012 Jul; 66(1):1-6. PubMed ID: 22465143
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of serum haptoglobin levels and Hp1-Hp2 polymorphism in the haptoglobin gene in patients with atrial fibrillation.
Costa LBX; Martins GL; Duarte RCF; Rocha PL; Figueiredo EL; Silveira FR; das Graças Carvalho M; Reis HJ; Gomes KB; Ferreira CN
Mol Biol Rep; 2022 Aug; 49(8):7359-7365. PubMed ID: 35576050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
